gamma-aminobutyric acid has been researched along with Tauopathies in 3 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laurent, C | 1 |
| Burnouf, S | 1 |
| Ferry, B | 1 |
| Batalha, VL | 1 |
| Coelho, JE | 1 |
| Baqi, Y | 1 |
| Malik, E | 1 |
| Mariciniak, E | 1 |
| Parrot, S | 1 |
| Van der Jeugd, A | 1 |
| Faivre, E | 1 |
| Flaten, V | 1 |
| Ledent, C | 1 |
| D'Hooge, R | 1 |
| Sergeant, N | 1 |
| Hamdane, M | 1 |
| Humez, S | 1 |
| Müller, CE | 1 |
| Lopes, LV | 1 |
| Buée, L | 1 |
| Blum, D | 1 |
| Hampton, DW | 1 |
| Webber, DJ | 1 |
| Bilican, B | 1 |
| Goedert, M | 1 |
| Spillantini, MG | 2 |
| Chandran, S | 1 |
| Iovino, M | 1 |
| Vuono, R | 1 |
3 other studies available for gamma-aminobutyric acid and Tauopathies
| Article | Year |
|---|---|
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Animals; Cognition Disorders; Disease Models, | 2016 |
Cell-mediated neuroprotection in a mouse model of human tauopathy.
Topics: Age Factors; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell Trans | 2010 |
Release of growth factors by neuronal precursor cells as a treatment for diseases with tau pathology.
Topics: Analysis of Variance; Animals; Brain-Derived Neurotrophic Factor; Cell Differentiation; Disease Mode | 2011 |